Form 4 for EW Edwards Lifesciences
Accepted 2022-04-11 00:00:00 ET · period of report 2022-04-11 · accession 0001225208-22-005751 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-11 | 2022-04-11 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $122.04 | -20.0K | 44.0K | -31% | -$2.44M |
| D | 2022-04-11 | 2022-04-11 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +20.0K | 47.6K | +73% | +$435.2K |
| D | 2022-04-11 | 2022-04-11 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $0.00 | -20.0K | 23.4K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-11 | S | D | 9,821 | $121.37 | 27,568.66 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $120.8475 to $121.8300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2022-04-11 | S | D | 6,579 | $123.00 | 37,389.66 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $122.9600 to $123.4000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-04-11 | S | D | 3,600 | $122.12 | 43,968.66 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $121.8500 to $122.7100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2022-04-11 | M | A | 20,000 | $21.76 | 47,568.66 | D | — | — | |
| 5 | Derivative | Employee Stock Option (Right to Acquire) | 2022-04-11 | M | D | 20,000 | $0.00 | 23,400 | D | $21.76 · 2016-05-14 to 2022-05-13 | 20,000 Common Stock |